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Abstract
Background: This study evaluated the protective effect of Echinatin against myocardial ischemia/reperfusion (I/R)
injury in rats.
Methods: The effect of Echinatin on cardiac function in rats subjected to I/R was demonstrated through improved
Langendorff retrograde perfusion technology. Adult Sprague–Dawley rats were randomly divided into five groups,
and myocardial infarct size was macroscopically estimated through 2,3,5-triphenyltetrazolium chloride staining.
The coronary effluent was analyzed for the release of lactate dehydrogenase (LDH) and creatine kinase (CK)
to assess the degree of cardiac injury. The concentrations of malondialdehyde (MDA), interleukin-6 (IL-6), and
tumor necrosis factor-α (TNF-α) were determined along with superoxide dismutase (SOD) activity using ELISA.
Finally, cardiomyocyte apoptosis analysis was conducted with POD, an in situ cell death detection kit.
Results: Echinatin (0.5 and 2.5 μg/mL) pretreatment enhanced the maximum up/down rate of the left ventricular
pressure (±dp/dtmax), improved the heart rate, increased the left ventricular developed pressure (LVDP), enhanced
the coronary flow, and reduced the CK and LDH levels in the coronary flow of the treated group compared with the
I/R group. Echinatin limited the contents of CK and LDH, improved the LVDP, reduced the contents of MDA, IL-6, and
TNF-α, and increased the SOD activity. The infarct size and cell apoptosis in the hearts of the rats in the
Echinatin-treated group were smaller and lower, respectively, than those in the hearts of the rats in the I/R
control group.
Conclusion: Echinatin exerts a protective effect against I/R-induced myocardial injury on hearts. This effect
may be attributed to the antioxidant and anti-inflammatory activities of this compound.
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Background
Cardiovascular diseases (CVDs) are the main cause of
morbidity and mortality all over the world [1]. Theoret-
ically, restoring blood supply to the ischemic myocar-
dium can reduce myocardial injury; however, reperfusion
can aggravate the myocardial damage caused by ische-
mia/reperfusion (I/R) injury [2]. A patient’s condition
can be seriously exacerbated by such injury, and thus
the prevention of I/R is important in alleviating ischemic
heart disease.
I/R injury is an intricate process that implicates many
mechanisms, such as oxidative damage [3]. Several stud-
ies revealed that the oxidative stress caused by reactive
oxygen species (ROS) plays a significant role in such in-
jury and impairs cardiac function. I/R causes an imbal-
ance between antioxidants and toxic free radicals, and
this imbalance increases the susceptibility of tissues to
oxidative damage through lipid peroxidation and protein
oxidation [4, 5]. Apoptosis and inflammation also play
important roles in the progression of I/R injury. Several
works reported that antiapoptosis and anti-inflammation
protect the heart from I/R injury and provide additional
evidence suggesting that both mechanisms are factors in
this injury [6, 7]. Therefore, the antioxidants and anti-
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inflammatory drugs obtained from plants represent a lo-
gical therapeutic strategy to treat I/R injury.
The licorice (liquorice) plant has a long and storied his-
tory of use in both Eastern and Western cultures. Some lic-
orice extracts exhibit unique antioxidant properties and
anti-inflammatory activities; in particular, licochalcones B
to D exert antioxidative and cardioprotective effects [8–10].
Echinatin (molecular formula: C16H14O4; Fig. 1) is a licorice
extract that displays antioxidant properties and anti-
inflammatory activities [11]. Therefore, the present study
evaluates the mechanisms and effects of Echinatin in rats
with I/R.
Methods
Test compounds, chemicals, and reagents
Echinatin (purity ≥ 98 %) was purchased from Chengdu
Must Biotechnology Co., Ltd. (Chengdu, China). 1,1,3,3-
Tetramethoxypropane was obtained from Fluka Chem-
ical Co. (Ronkonkoma, NY). 2,3,5-Triphenyltetrazolium
chloride (TTC) and both oxidized and reduced glutathi-
ones were purchased from Sigma Chemical Co. (St. Louis,
MO). The other chemicals and reagents used were of ana-
lytical grade.
Animals and experimental groups
Adult Sprague–Dawley rats (Jinan Jinfeng Experimental
Animal Breeding Co., Ltd.; License Number: SCXK(lu)
2014–0006) weighing 250–300 g were housed in the
animal facility of the Yantai Yuhuangding Hospital
Experimental Animal Center in accordance with the in-
stitutional guidelines. The rats were randomly divided
into five groups: control (sham), I/R, and Echinatin (0.1,
0.5, and 2.5 μg/mL) treatment groups. Hearts in the con-
trol group were stabilized for 30 min and perfused for
65 min, there is not zero-flow global ischemia in whole
process. The hearts of the rats in the I/R group were
subjected to 20 min of zero-flow global ischemia and
45 min of reperfusion after stabilization. The hearts of
the rats in the treatment groups were stabilized for
30 min and then treated with a Krebs–Henseleit (K–H)
buffer solution containing Echinatin (0.1, 0.5, and
2.5 μg/mL). Global ischemia and reperfusion were estab-
lished for 45 min.
I/R model establishment
Sprague Dawley rats (250–300 g) were anesthetized with
an intraperitoneal injection of 60 mM chloral hydrate
(0.35 g/kg). To prevent coagulation of the blood, 250 U/kg
of heparin were administered intraperitoneally. The heart
was then excised quickly by thoracic surgery and immedi-
ately mounted on Langendorff ’s apparatus. The hearts
were immersed in ice-cold Krebs-Henseleit buffer
(118 mM NaCl, 1.2 mM KH2PO4, 4.7 mM KCl, 1.7 mM
CaCl2, 1.2 mM MgSO4, 20 mM sodium acetate and
10 mM glucose, pH 7.4), equilibrated with a gas mixture
comprised of 95 % O2/5 % CO2 at 37 °C, and then main-
tained in a water-jacketed organ chamber at 37 °C. A
water-filled latex balloon coupled to a pressure transducer
(Statham) was inserted into the left ventricular cavity via
the left auricle for recording pressure.
This study evaluated cardiac function by monitoring
hemodynamic parameters, which are important indices
of cardiac function. The Echinatin dose applied in the
experiments was determined through preliminary exper-
iments, wherein Echinatin was tested at doses of 0.1, 0.5,
and 2.5 μg/mL. The following functional parameters
were continuously monitored with a computer-based
data acquisition system (PC PowerLab with Chart 5, 4S
AD Instruments): left ventricular developed pressure
(LVDP), maximum rise/down velocity of left intraven-
tricular pressure (dp/dtmax and dp/dtmin) and coronary
flow (CF). The heart effluents were collected at 1 min
intervals to determine the coronary flow (CF). The re-
covery of LVDP, dp/dtmax, dp/dtmin and CF were
expressed as the percent of 1 min before ischemia.
Measurement of cellular injury
The levels of lactate dehydrogenase (LDH) and creatine
kinase (CK) released were measured to evaluate the occur-
rence of necrotic cell death. After the experiment, these
levels in the perfusate were spectrophotometrically deter-
mined with cytotoxicity detection kits for LDH and CK
(Nanjing Jiancheng Biological Product, Nanjing, China).
Evaluation of myocardial infarct size
The artery was occluded for 20 min and then reperfused
for 45 min prior to terminating the experiment based on
successful ischemia and reperfusion methods previously
used in the same experimental model. To assess tissue
death, the hearts were removed and washed in
phosphate-buffered saline, frozen, stored at −20 °C for
30 min, and then sliced into 1 mm-thick sections per-
pendicularly along the long axis from the apex to the
base. The slices were incubated in 1 % TTC of the
pH 7.4 buffer at 37 °C for 10–15 min, fixed in 10 % for-
maldehyde solution, and then photographed with a
digital camera to distinguish the red-stained viable tis-
sues from the white-unstained necrotic tissues. The red-
Fig. 1 Chemical structure of Echinatin
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and white-stained areas were measured using an Image-
Pro Plus 7.0 instrument (Media Cybernetics, Wyoming,
USA). The percentage of infarction size was calculated
with the following equation: %Infarct volume = Infarct
volume/Total volume of slice × 100.
Assay of oxidative stress and inflammation
At the end of the experiment, the hearts were harvested
and maintained at −70 °C for subsequent analysis. The
frozen ventricles were crushed to powder by a liquid
nitrogen-chilled tissue pulverizer. The weighed amount
of frozen tissues was homogenized in the appropriate
buffer using a microcentrifuge tube homogenizer for tis-
sue analysis.
Superoxide dismutase (SOD) activity and the levels of
malondialdehyde (MDA), tumor necrosis factor-α (TNF-
α), and interleukin-6 (IL-6) were spectrophotometrically
analyzed through ELISA (Tsz Biosciences, Greater Boston,
USA) according to the manufacturer’s instructions.
Terminal deoxynucleotidyl transfer-mediated dUTP nick
end-labeling (TUNEL) staining
We conducted TUNEL staining using POD, an in situ cell
death detection kit (Roche, Germany), according to the
manufacturer’s instructions. Following deparaffinization
and rehydration, the sections were treated with 10 mM
protease K for 15 min. The slides were immersed in a
TUNEL reaction mixture for 60 min at 37 °C in a
Fig. 2 Effect of Echinatin on the cardiac function of rats subjected to I/R. Effect of Echinatin on (a) LVDP, (b) CF, (c) dp/dtmax, and (d) dp/dtmin in rat
hearts. (Values are expressed as mean ± SD, n = 6). ##P < 0.01 compared with the control group; *P < 0.05, **P < 0.01 compared with the I/R group
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humidified atmosphere in the dark. The slides were incu-
bated in Converter-POD for 30 min to show blue nuclear
staining and then analyzed via optical microscopy. The
TUNEL index (%) was computed by dividing the ratio of
the number of TUNEL-positive cells by the total number
of cells; this index was considered in evaluating the apop-
tosis index of TUNEL-stained heart tissues. Eight ran-
domly selected areas of TUNEL-stained slices were
counted for each sample, and the average value was
calculated.
Statistical analysis
The data were presented as mean ± SD from at least
three independent experiments and were assessed
through Student’s t-test. Statistical significance was set
to p < 0.05, and the statistical analysis was conducted
with SPSS (IBM SPASS, International Business Machines
Corporation, USA).
Results
Echinatin enhances the recovery of I/R-altered cardiac
function
Hemodynamic parameters were continuously monitored
using a computer-based data acquisition system. The
effects Echinatin of treatment on LVDP, ±dp/dtmax and
CF are shown in Fig. 2. The functional recovery of the
Echinatin-treated hearts was significantly greater than
that of the unprotected I/R hearts during reperfusion. In
Fig. 3 Effect of Echinatin on (a) LDH and (b) CK levels in coronary effluent during I/R injury (Values are expressed as mean ± SD, n = 6). ##P < 0.01
compared with the control group; *P < 0.05, **P < 0.01 compared with the I/R group
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particular, Echinatin doses of 0.5 and 2.5 μg/mL im-
proved LVDP and -dp/dtmax considerably (*p < 0.05,
**p < 0.01, respectively); in addition, a 2.5 μg/mL dose
significantly enhanced + dp/dtmax (*p < 0.05) and CF
(**p < 0.01).
Echinatin attenuated the release of I/R-induced enzymes
in rat hearts
This study measured the release of LDH and CK to
evaluate the degree of myocardial injury. This method
was used in previous studies to determine the occur-
rence of necrotic cell death prior to ischemia. After
20 min of ischemia that was followed by 30 min of re-
perfusion, CK and LDH leakage was notably greater in
the I/R group than in the control group (Fig. 3). Echina-
tin pretreatment at doses of 0.5 and 2.5 μg/mL signifi-
cantly reduced the I/R-induced increase in the LDH and
CK releases in the rat hearts (**p < 0.01, *p < 0.05, and
**p < 0.01).
Echinatin reduced the I/R-induced infarct size
As shown in Fig. 4, myocardial infarct size can indi-
cate myocardial injury. The infarct area increased
significantly in the rat hearts in the I/R group
(55.24 % ± 3.56 %). By contrast, 0.5 and 2.5 μg/mL of
Echinatin treatment reduced I/R-induced myocardial
infarct size by 15.49 % ± 1.98 % and 8.97 % ± 1.51 %,
respectively (**p < 0.01).
Echinatin alleviated the oxidative stress induced by I/R
injury on myocardial tissues
ROS generation is a major factor in I/R injury. To identify
the possible mechanisms of Echinatin on cardioprotection,
the MDA level and SOD activity were determined in the
myocardial tissue. These indicators were also calculated in
such tissues to identify the possible mechanisms under-
lying the cardioprotective effects of Echinatin. Pretreat-
ment with 2.5 μg/mL of Echinatin significantly increased
the SOD activity (Fig. 5a) (**p < 0.01), whereas pretreat-
ment with 0.5 and 2.5 μg/mL Echinatin doses considerably
lowered the MDA level (Fig. 5b) (*p < 0.05 and **p < 0.01,
respectively).
Echinatin attenuated the myocardial tissue inflammation
induced by I/R injury
Inflammation is an important mechanism underlying
myocardial I/R injury. The presence of the inflammatory
cytokines (e.g., IL-6 and TNF-α) associated with I/R in-
jury was determined in myocardial tissues to identify the
possible mechanisms behind the cardioprotective activity
of Echinatin. Moreover, the IL-6 and TNF-α activities
were measured. The TNF-α content in the groups
Fig. 4 Effect of Echinatin on the reduction of I/R-induced infarct size. (a) The myocardial infarct size; (b) The infarct size shown as percentage.
(Values are expressed as mean ± SD, n = 6). ##P < 0.01 compared with the control group; **P < 0.01 compared with the I/R group
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pretreated with Echinatin at 0.5 (189.31 ± 4.82 pg/mL)
and 2.5 μg/mL (132.72 ± 7.04 pg/mL) was significantly
lower (**p < 0.01) than that in the I/R group (258.35 ±
23.18 pg/mL) (Fig. 6a). The IL-6 activity decreased from
74.92 ± 5.46 pg/mL in the I/R group to 56.96 ± 3.54 pg/
mL in the group pretreated with 2.5 μg/mL Echinatin
(**p < 0.01) (Fig. 6b).
Echinatin minimized the cardiomyocyte apoptosis
induced by I/R injury
This section discusses the results of the myocardial is-
chemic reperfusion in the event of cardiomyocyte apop-
tosis, which was observed in this study via TUNEL
staining. As illustrated in Fig. 7, this staining highlighted
the lack of apoptosis in the control group under optical
microscopy. The number of apoptotic cells increased
considerably in the I/R group but visibly declined in the
groups pretreated with Echinatin at doses of 0.5 and
2.5 μg/mL (**p < 0.01).
Discussion
We investigated the effects of Echinatin on cardiac
function, myocardial enzymes, inflammatory factors,
and cardiomyocyte apoptosis in the I/R model of an
isolated rat heart. We then confirmed that Echinatin
improves cardiac function recovery, reduces intracel-
lular oxidation status, and inhibits I/R-induced cardio-
myocyte apoptosis.
Fig. 5 Effects of Echinatin on the (a) SOD activity and (b) MDA level of isolated rat hearts subjected to I/R (Values are expressed as mean ± SD, n
= 6). ##P < 0.01 compared with the control group; *P < 0.05, **P < 0.01 compared with the I/R group
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Myocardial I/R results in heart dysfunction [8, 9]. We
observed significant myocardial dysfunction, including
changes in hemodynamic parameters (LVDP, ±dp/dtmax
and CF), release of enzymes (CK and LDH), and induced
myocardial infarct after myocardial I/R. These phenomena
agree with the results of numerous reports, indicating that
reperfusion is a key initiator of myocardial dysfunction as-
sociated with I/R injury. Echinatin significantly improved
the recovery of I/R-altered hemodynamic parameters
(LVDP, ±dp/dtmax and CF), decreased I/R-induced en-
zyme release (CK and LDH) and reduced infarct size.
Researchers have reached a consensus that oxidative
stress can trigger significant myocardial injury after I/R
through certain pathways [12, 13]. During reperfusion,
excessive amounts of ROS are generated by myocardial
cell mitochondria and xanthine oxidase pathways; these
amounts are beyond the endogenous capability of cells.
MDA (a critical component of the NADPH oxidase) is
produced through lipid peroxidation, myocardial en-
zymes are released, structural proteins are attacked, and
cell structures are destroyed [14, 15]. As oxidative stress
is a crucial event in I/R injury, oxidative stress inhibition
is considered a viable approach to treat I/R-induced
cardiac injury. In this experiment, Echinatin treatment
significantly reduced the MDA content in I/R rats and
improved the I/R-induced deterioration of total antioxi-
dant capacity (SOD activity). Thus, Echinatin plays a
cardioprotective role by regulating oxidative stress.
Fig. 6 Effect of Echinatin on (a) TNF-α and (b) IL-6 levels in rats subjected to I/R (Values are expressed as mean ± SD, n = 6). ##P < 0.01 compared
with the control group; *P < 0.05, **P < 0.01 compared with the I/R group
Tian et al. BMC Cardiovascular Disorders  (2016) 16:119 Page 7 of 9
Inflammation, which plays an important role in many dis-
ease states, is associated with enhanced expression of adhe-
sive molecules in the vasculature, resulting in the
infiltration of larger populations of neutrophils and mono-
cytes/macrophages. The release of pro-inflammatory cyto-
kines from these activated leukocytes can then in turn
cause tissue damage [16]. Several lines of evidence suggest
that I/R induces vigorous inflammatory reactions, such as a
significant increase in the levels of IL-6 and TNF-α in the
myocardial tissue. These proinflammatory cytokines from
these activated leukocytes can then in turn cause tissue
damage [17, 18]. Along these lines, inflammation plays a
key role in cardiac I/R injury, and the deleterious events
that follow these events include an increased release of
proinflammatory mediators (e.g., TNF-α, CRP and IL-6).
To investigate the relationship between the anti-
inflammatory and cardioprotective effects of Echinatin, an
experiment was conducted to determine whether or not this
extract affected the I/R-induced changes in IL-6 and TNF-α.
The findings showed that I/R increased the production of
these cytokines, whereas Echinatin treatment reduced their
concentrations. Overall, this extract may inhibit myocardial
I/R injury through anti-inflammatory activities.
Such injury results in heart dysfunction and cardiomyo-
cyte apoptosis [19, 20]. In fact, several studies have clari-
fied the deleterious effects of I/R injury [21]. In our
experiments, Echinatin treatment improved cardiac func-
tion recovery and significantly reduced the apoptotic
Fig. 7 Effects of Echinatin on the suppression of cardiomyocyte apoptosis (×200). The brown nucleus indicates the apoptotic cardiomyocyte
nucleus. (a) The TUNEL staining; (b) Percentage of apoptotic cells. (Values are expressed as mean ± SD, n = 6). ##P < 0.01 compared with the
control group; **P < 0.01 compared with the I/R group
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index of rats after I/R. Thus, this compound can protect
the heart by minimizing apoptosis.
Conclusions
Echinatin facilitated cardioprotection against myocardial
I/R injury, and this capability may be attributed to its
antioxidant, anti-inflammatory, and anti-apoptotic ac-
tivities. Thus, we hypothesize that Echinatin deserves
additional experimental and clinical research in the
cardiovascular milieu.
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